Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacral Submultifidus Block as an Adjunct to Sacroiliac Joint Injection
NCT07814729Recruiting
- Sponsor
- Fayoum University Hospital
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine and dexamethasone in sacroiliac joint dysfunction, low back pain (LBP) and Sacroiliitis (SIJ) (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Visual Analog Scale at 6 months. Started Sep 2026; status: recruiting.
02
Drugs
bupivacainedexamethasone
03
Conditions
sacroiliac joint dysfunctionlow back pain (LBP)Sacroiliitis (SIJ)
Beyond the preview
Go deeper on NCT07814729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814729.